Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.372 SEK | +0.54% | -3.88% | -14.87% |
Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 61M 5.58M | Sales 2025 * | 82.4M 7.53M | Capitalization | 85.69M 7.83M |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.66M | Net income 2025 * | -32M -2.93M | EV / Sales 2024 * | 0.81 x |
Net cash position 2024 * | 36M 3.29M | Net cash position 2025 * | 38M 3.47M | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-1.86
x | P/E ratio 2025 * |
-3.72
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.36% |
1 day | +0.54% | ||
1 week | -3.88% | ||
Current month | +1.09% | ||
1 month | +0.81% | ||
3 months | -11.00% | ||
6 months | -21.02% | ||
Current year | -14.87% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Hultman
CEO | Chief Executive Officer | 50 | 18-11-30 |
Lars Jakobsson
DFI | Director of Finance/CFO | 67 | - |
Gustav Sten
COO | Chief Operating Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 21-12-31 | |
Director/Board Member | 63 | 21-04-30 | |
Clas Runnberg
BRD | Director/Board Member | 72 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.372 | +0.54% | 37,651 |
24-04-25 | 0.37 | +1.37% | 32,397 |
24-04-24 | 0.365 | -3.69% | 92,141 |
24-04-23 | 0.379 | +0.26% | 46,652 |
24-04-22 | 0.378 | -2.33% | 54,620 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 10:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.87% | 7.82M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AROC Stock